INT Medical Completes Full H-Share Circulation, Converts 71.79 Million Domestic Shares

Bulletin Express06-03

Shanghai INT Medical Instruments Co., Ltd. (INT Medical) announced the successful completion of its H-share full-circulation plan. On 3 June 2026, 71.79 million domestic shares were converted into H shares, raising the total number of H shares to 211.20 million. Trading in the newly converted shares will begin on the Hong Kong Stock Exchange at 09:00 on 4 June 2026.

Before the conversion, INT Medical’s share structure comprised 139.41 million H shares (66.01%) and 71.79 million domestic shares (33.99%). Following the transaction, H shares account for 100% of the 211.20 million total shares outstanding, eliminating the domestic-share class entirely.

The company reiterated that shareholders and potential investors should exercise caution when dealing in INT Medical’s securities.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment